ABOUT THE CONFERENCE

In order to ensure robust market access and reimbursement of medical products and technologies, medical device industry executives must craft an intricate coverage plan which transcends multiple layers of stakeholders and decision makers, from the public and private payer community, to coding administrators and hospital purchasing and value analysis committees. Striking a delicate balance which provides the appropriate type and level of evidence to support product value proposition throughout the healthcare supply chain is now an essential component of reimbursement and market access, and more important than ever before. Through discussions led by forward thinking stakeholders and industry executives, participants in the 14th Annual Medical Device Coverage & Reimbursement Conference will have an opportunity to not only hear from leaders in the field on the craft of medical device reimbursement, but also from stakeholders directly on how to best create a collaborative, productive engagement strategy which ensures product access.

Testimonials:

“The program, content, attendees and format were beyond our expectations. We appreciated the opportunity to work with Q1 on this meeting and look forward to participation and contributing to the conversation in the future.”
– VP Sales & Operations, PRIA HEALTHCARE MANAGEMENT

“Content was at the caliber I had hoped for. Excellent content, great speakers; especially the payer panel, very valuable.”
– Principal & Owner, ANR CONSULTING

“The information presented was in-line with my expectations.”
– Sr. Director, Payer, Pricing & Tenders, JOHNSON & JOHNSON

ABOUT THE CONFERENCE

In order to ensure robust market access and reimbursement of medical products and technologies, medical device industry executives must craft an intricate coverage plan which transcends multiple layers of stakeholders and decision makers, from the public and private payer community, to coding administrators and hospital purchasing and value analysis committees. Striking a delicate balance which provides the appropriate type and level of evidence to support product value proposition throughout the healthcare supply chain is now an essential component of reimbursement and market access, and more important than ever before. Through discussions led by forward thinking stakeholders and industry executives, participants in the 14th Annual Medical Device Coverage & Reimbursement Conference will have an opportunity to not only hear from leaders in the field on the craft of medical device reimbursement, but also from stakeholders directly on how to best create a collaborative, productive engagement strategy which ensures product access.